We use cookies to measure traffic and show relevant ads. By clicking Accept you agree to our use of analytics and advertising cookies.
FDA批准Fasenra（贝那利珠单抗）用于HES治疗。恶化风险降低65%，并具有类固醇节省效应。了解这如何改变生物类似药市场。
